Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
N-[4-(2-Chloroethyl)-2,5-dimethylphenyl]acetamide → N-(4-{2-[4-(1H-Indazol-3-YL)-piperazin-1-YL]-ethyl}-2.5-dimethyl-phenyl)-acetamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | N-[4-(2-Chloroethyl)-2,5-dimethylphenyl]acetamide | HCID 21963433 | — |
| 반응물 | 3-(Piperazin-1-yl)-1H-indazole hydrochloride | HCID 21963434 | — |
| 생성물 | N-(4-{2-[4-(1H-Indazol-3-YL)-piperazin-1-YL]-ethyl}-2.5-dimethyl-phenyl)-acetamide | HCID 21963196 | — |
반응 단계
N-[4-(2-Chloro-ethyl)-2,5-dimethyl-phenyl]-acetamide (0.142 g, 0.631 mmol) was reacted with 3-piperazin-1-yl-1H-indazole hydrochloride (0.226 g, 0.946 mmol) according to the method outlined in Example 501.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07101886B2 |
| 출처 데이터셋 | uspto-grants-2006_09 |
| ORD ID | ord-cf021d051ce44bdc8dbf5e0733046c52 |
| 출처 메모 | uspto-grants-2006_09 |